- Home
- LEGN vs MKSI Comparison
LEGN vs MKSI Comparison
Compare LEGN & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- MKSI
- Stock Information
- Founded
- LEGN 2014
- MKSI 1961
- Country
- LEGN United States
- MKSI United States
- Employees
- LEGN N/A
- MKSI N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- MKSI Industrial Machinery/Components
- Sector
- LEGN Health Care
- MKSI Industrials
- Exchange
- LEGN Nasdaq
- MKSI Nasdaq
- Market Cap
- LEGN 6.7B
- MKSI 7.1B
- IPO Year
- LEGN 2020
- MKSI 1999
- Fundamental
- Price
- LEGN $33.11
- MKSI $115.10
- Analyst Decision
- LEGN Strong Buy
- MKSI Buy
- Analyst Count
- LEGN 12
- MKSI 10
- Target Price
- LEGN $73.36
- MKSI $121.70
- AVG Volume (30 Days)
- LEGN 1.1M
- MKSI 951.7K
- Earning Date
- LEGN 11-11-2025
- MKSI 11-05-2025
- Dividend Yield
- LEGN N/A
- MKSI 0.76%
- EPS Growth
- LEGN N/A
- MKSI 3206.74
- EPS
- LEGN N/A
- MKSI 3.95
- Revenue
- LEGN $796,838,000.00
- MKSI $3,741,000,000.00
- Revenue This Year
- LEGN $70.75
- MKSI $8.76
- Revenue Next Year
- LEGN $52.47
- MKSI $5.74
- P/E Ratio
- LEGN N/A
- MKSI $29.17
- Revenue Growth
- LEGN 74.75
- MKSI 4.50
- 52 Week Low
- LEGN $27.34
- MKSI $54.84
- 52 Week High
- LEGN $52.31
- MKSI $125.33
- Technical
- Relative Strength Index (RSI)
- LEGN 36.16
- MKSI 67.45
- Support Level
- LEGN $33.20
- MKSI $97.50
- Resistance Level
- LEGN $34.71
- MKSI $102.45
- Average True Range (ATR)
- LEGN 1.22
- MKSI 3.46
- MACD
- LEGN -0.09
- MKSI 1.15
- Stochastic Oscillator
- LEGN 10.96
- MKSI 93.52
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About MKSI MKS Instruments Inc.
MKS Inc formerly, MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others, used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.